Kearbey, Jeffrey D.
Mayo Clinic
Pharmacyclics LLC an AbbVie Company South San Francisco California USA
Citations 1
Ibrutinib (Ibr) dose modification for management of early cardiac adverse events in patients with chronic lymphocytic leukemia: Pooled analysis of 7 clinical trials
Tedeschi, Alessandra , Ahn, Inhye E. , Fraser, Graeme , Greil, Richard , Saifan, Chadi , Kearbey, Jeffrey D., Patel, Sandipkumar , Munir, Talha , Kay, Neil E. , Flinn, Ian W. , Lee, Shane , Barrientos, Jacqueline C.
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 461-463
